MDF updates information on the Department of Defense’s Peer Reviewed Medical Research Program first described in the April Research News.
NINDS has a strong program to support preclinical therapy development and has released three additional initiatives to support work in academia or industry.
Intronic GC-rich microsatellite expansions are common in neurological disorders and act to trigger the intronic retention that underlies disease pathogenesis.
Methodology is reported for robust and reliable quantification of mutant and abberantly spliced RNA in cells from DM patients.
Some of you may have watched the news show, 60 Minutes, on April 29th. The 60 Minutes piece of interest to everyone with an inherited disease, like DM, was titled: “CRISPR: The Gene-Editing Tool Revolutionizing Biomedical Research”.